Eli Lilly jet lands in Washington the week of FDA policy talks

Eli Lilly, the Indianapolis-based pharmaceutical giant, flew from its Indianapolis International base to a Washington, D.C.-area airport on May 22nd, a 1-hour-23-minute hop aboard its Gulfstream G500 (N307EL). The trip lands the company's leadership within miles of the capital as federal health policy conversations intensify.

The same week, Eli Lilly faces renewed scrutiny over drug pricing and Medicare negotiations. The Inflation Reduction Act's next round of price-setting talks is expected to include Lilly's blockbuster diabetes drug Mounjaro, per agency filings cited by Reuters this week. A company Gulfstream parked near D.C. signals meetings with regulators, legislators, or industry coalitions — the usual choreography of a drugmaker managing its most consequential policy exposure.

This Gulfstream G500 has been active: it shuttled to Boston and New York earlier in the week, then returned home on May 21st before today's Washington run. Eli Lilly has operated Gulfstreams for more than half a century, and N307EL is one of three G500s in its flight department. The pattern suggests a week of east-coast policymaker and investor conversations, bookended from Indiana.